Dr. Agarwals Health Care Ltd (AGARWALEYE) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Dr. Agarwals Health Care Ltd on NSE and BSE, with an AI summary of each filing.
DR. AGARWAL'S HEALTH CARE LIMITED has informed the Exchange about Board Meeting to be held on 05-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 05 Nov 2026, 5:30 am
Dr. Agarwal's Health Care Limited has informed the Exchange about Schedule of meet
Intimation · 05 Nov 2026, 5:30 am
Intimation of Analyst / Earnings Conference call to discuss the Unaudited Financial Results (Standalone & Consolidated) of the Company for the Quarter and Half-Year ended September 30, ....
Intimation · 05 Nov 2026, 6:30 pm
Dr. Agarwal’s Health Care Board Meeting and Earnings Call Scheduled for 5th Nov'26 Dr. Agarwal’s Health Care Limited will convene its Board of Directors meeting on 5th Nov'26 to consider and approve standalone and consolidated unaudited financial results for the quarter and half-year ended 30th Sep'26. The company’s insider trading window remains closed until 48 hours post-result declaration. Following the board meeting, senior management—including CEO Dr. Adil Agarwal and CFO Yashwanth Venkat—will host an earnings conference call for investors and analysts on 5th Nov'26 at 06:30 PM IST to discuss the results.
To consider and approve the financial results for the period ended September 30, 2026
Intimation · 05 Nov 2026, 5:30 am
Dr. Agarwals Health Care Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve the Unaudited Financial ....
Intimation · 05 Nov 2026, 5:30 am
Dr. Agarwal’s Health Care Schedules Board Meeting and Q2 Earnings Call Dr. Agarwal’s Health Care Limited will convene its Board of Directors meeting on 5th Nov'26 to consider and approve unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. The company will subsequently host an earnings and analyst conference call on 5th Nov'26 at 06:30 PM IST to discuss the results, led by the CEO, CFO, and Head of IR. The insider trading window remains closed until 48 hours post-announcement.
Allotment of 18,200 Equity Shares pursuant to the exercise of options granted under Dr. Agarwal''s Health Care Limited - Employees Stock Option Scheme 2022
Others (Uncategorized) · 21 Oct 2026, 12:48 am
Dr. Agarwal’s Health Care Allots 18,200 Equity Shares Under ESOP Scheme 2022 The Nomination and Remuneration Committee of Dr. Agarwal’s Health Care Limited approved the allotment of 18,200 equity shares of face value ₹1 each on 20th Oct'26 under the Employees Stock Option Scheme 2022. The allotment comprises 8,200 shares at an exercise price of ₹129.88 per share and 10,000 shares at ₹135.00 per share. Consequently, the company's paid-up equity share capital increased from ₹31,70,26,183 to ₹31,70,44,383, consisting of 31,70,44,383 equity shares. The newly allotted shares rank pari passu with existing shares.
Fixation of Record Date w.r.t. the Scheme of Amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited, is disclosed.
Others · 21 Oct 2026, 12:42 am
Dr. Agarwal’s Health Care Approves Merger and Sets Swap Record Date Dr. Agarwal’s Health Care approved the Scheme of Amalgamation with Dr. Agarwal’s Eye Hospital, effective 1st Nov'26, with an Appointed Date of 1st Apr'26. The NCLT order was filed with the ROC on 15th Oct'26. The record date for share allotment is set for 18th Nov'26. Eligible shareholders will receive 23 equity shares (FV ₹1) of Dr. Agarwal’s Health Care for every 2 equity shares (FV ₹10) held in Dr. Agarwal’s Eye Hospital. Post-merger, authorized share capital expands to ₹110 crore.
Outcome of Board Meeting held on October 20, 2026 in connection with a Material Update on Scheme of Amalgamation between Dr. Agarwal''s Eye Hospital Limited and Dr. Agarwal''s Health Care ....
Others (Uncategorized) · 21 Oct 2026, 12:20 am
Dr. Agarwal’s Health Care Approves Merger Effectiveness and Share Swap Ratio Dr. Agarwal’s Health Care Limited announced that its scheme of amalgamation with Dr. Agarwal’s Eye Hospital Limited becomes effective on 1st Nov'26, following NCLT sanction and ROC filing on 15th Oct'26, with an appointed date of 1st Apr'26. The board fixed 18th Nov'26 as the record date for share allotment. Eligible shareholders will receive 23 equity shares (FV ₹1) of Dr. Agarwal’s Health Care for every 2 equity shares (FV ₹10) held in Dr. Agarwal’s Eye Hospital. Post-merger authorized capital expands to ₹110 cr.
Receipt of sanction from the Honble NCLT, Chennai Bench towards the scheme of amalgamation between Dr. Agarwals Eye Hospital Limited and Dr. Agarwals Health Care Limited and their respective ....
Others (Uncategorized) · 06 Oct 2026, 4:10 am
NCLT Approves Scheme of Amalgamation of Dr. Agarwal’s Eye Hospital into AHCL The NCLT Chennai Bench sanctioned the Scheme of Amalgamation of Dr. Agarwal’s Eye Hospital Limited (AEHL) with and into Dr. Agarwal’s Health Care Limited (AHCL) via an order pronounced on 30th Sep'26. The scheme takes effect from the appointed date of 1st Apr'26 and becomes operative the month after fulfilling specified conditions. AHCL will notify stock exchanges regarding the effective date, record date fixation, share allotment under the exchange ratio, and other subsequent actions once formal certified orders are received.
Update on Step-down wholly owned subsidiary in Nigeria by Orbit Healthcare Services (Mauritius) Limited, a direct wholly owned subsidiary of the Company.
Others (Uncategorized) · 29 Sept 2026, 10:25 pm
Dr. Agarwal's Health Care Expands Presence with Step-Down Subsidiary in Nigeria Dr. Agarwal's Health Care Limited announced on 29th Sep'26 that Orbit Healthcare Services Nigeria Ltd. has officially become a wholly owned subsidiary of Orbit Healthcare Services (Mauritius) Limited. Consequently, the Nigerian entity now operates as an indirect, step-down wholly owned subsidiary of Dr. Agarwal's Health Care Limited, following up on the company's prior corporate proposal disclosed on 4th Aug'26.
Completion of Second Term of 5 (Five) Consecutive Years by Mr. Sanjay Anand (DIN: 02501139), Independent Director of the Company
Change in Management · 29 Sept 2026, 10:17 pm
Dr. Agarwal’s Health Care Reconstitutes Board Committees Following Director Tenure Completion Dr. Agarwal’s Health Care Limited announced that Independent Director Mr. Sanjay Anand ceased to be on the board at the close of business hours on 29th Sep'26 upon completing his second consecutive five-year term. Following his departure, the company reconstituted its board committees effective 29th Sep'26. The revised Audit and Stakeholders Relationship Committees are chaired by Mr. Balakrishnan Venkatraman, the Nomination & Remuneration Committee is headed by Ms. Archana Bhaskar, and the CSR and Risk Management Committees are chaired by Mr. Nachiket Madhusudan Mor.
Voting Results and the Consolidated Scrutinizer''s Report of the 16th AGM of the Company, is submitted.
Annual General Meeting · 22 Sept 2026, 1:51 am
Proceedings of the 16th Annual General Meeting of Dr. Agarwal''s Health Care Limited held on Monday, September 21, 2026, is submitted.
Annual General Meeting · 22 Sept 2026, 12:21 am
Annual Report of the Company for the Financial Year 2025-26, is submitted.
Others (Uncategorized) · 28 Aug 2026, 11:10 pm
Notice convening the Sixteenth AGM of the Company on September 21, 2026, along with the Annual Report for the financial year 2025-26, is submitted.
Annual General Meeting · 28 Aug 2026, 11:02 pm
Media Release - Launch of World''s First Pinhole Pupilloplasty (PPP) Centre by Dr. Agarwals Eye Hospital Limited, a subsidiary of the Company, is submitted
Press Release · 27 Aug 2026, 9:21 pm
Dr. Agarwal's Subsidiary Launches World's First Pinhole Pupilloplasty Centre Dr. Agarwal's Health Care, via its subsidiary Dr. Agarwal's Eye Hospital Ltd (AEHL), launched the world's first Pinhole Pupilloplasty (PPP) Centre in Chennai on 27 Aug'26. Developed by Chairman Dr. Amar Agarwal, the pioneering PPP technique treats complex corneal disorders without requiring donor tissue, addressing a significant global shortage. This specialized centre aims to advance tissue-preserving treatments for conditions like corneal scars and complex optical aberrations, enhancing access to a procedure that has already provided vision to over 5,000 patients.
Intimation of Schedule of Analyst / Investors Meet is submitted.
Intimation · 25 Aug 2026, 11:00 pm
Dr. Agarwal's Eye Hospital to Participate in Sep'26 Investor Conferences Dr. Agarwal's Health Care Ltd. (AGARWALEYE) announced its participation in two investor forums in Sep'26. Management will attend the Jefferies India Forum in Gurgaon on Sep 16 and the Kotak Healthcare Forum in Mumbai on Sep 17-18. Both events will feature physical group and one-on-one meetings with analysts and investors. The company confirmed that no unpublished price-sensitive information will be disclosed. The schedule is subject to change based on exigencies.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Acquisition/ Disposal of Shares · 25 Aug 2026, 4:27 pm
Pledge Created on Dr. Agarwal's Health Care Shares by Catalyst Trusteeship Catalyst Trusteeship, acting as an onshore security agent, created a pledge over 7,538,303 shares (2.38% of capital) of Dr. Agarwal's Health Care Limited on 21 Aug '26. This action is related to a USD 100M facility agreement from 26 Mar '24 involving borrower Hyperion Investments Pte. Ltd. The newly pledged shares were part of a larger block previously released on 11 Aug '26. After this transaction, the total shares encumbered with Catalyst Trusteeship increased to 49,033,988, representing 15.47% of the company's total share capital.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for DB International Trust (Singapore) Ltd
Acquisition/ Disposal of Shares · 14 Aug 2026, 10:17 pm
Dr. Agarwal's Health Care: Borrower Disposes Shares Following Pledge Release Deutsche Bank, as offshore security agent, disclosed a change in encumbered shares of Dr. Agarwal's Health Care. On 11 Aug'26, the onshore agent partially released a pledge over 31.7M shares held by Borrower Hyperion Investments. Following this, on 12 Aug'26, the Borrower sold 24.16M shares (7.62% of total capital). This transaction reduced the total encumbered shares held by the Borrower from 73.19M (23.09%) to 49.03M (15.47%). The original encumbrance was related to a USD 100M facility availed by Hyperion Investments.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Claymore Investments (Mauritius) Pte Ltd
Acquisition/ Disposal of Shares · 14 Aug 2026, 8:12 pm
Claymore Investments Sells Stake in Dr. Agarwal's Health Care On 12 Aug'26, Claymore Investments sold 1.59 crore shares of Dr. Agarwal's Health Care Ltd through an open market transaction. This sale represented 5.02% of the total share capital. Following the transaction, Claymore's individual stake decreased from 10.19% to 5.17%. The combined holding of Claymore and its Person Acting in Concert (PAC), Arvon Investments, reduced from 20.06% to 15.04%. This disclosure was made under SEBI's substantial acquisition regulations, as the sale crossed the 2% threshold.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Hyperion Investments Pte Ltd
Acquisition/ Disposal of Shares · 14 Aug 2026, 5:25 pm
Hyperion Investments Sells 7.6% Stake in Dr. Agarwal's Health Care Hyperion Investments Pte. Ltd. sold 24,160,000 equity shares of Dr. Agarwal's Health Care Limited through the stock exchanges on 12 Aug'26. This transaction represents 7.62% of the total share capital. Following the sale, Hyperion Investments' holding in the company has been reduced from 73,193,988 shares (23.09%) to 49,033,988 shares, which now constitutes a 15.47% stake. The disclosure was made under SEBI's takeover regulations. Hyperion is not part of the promoter group.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Invesco Mutual Fund
Acquisition/ Disposal of Shares · 14 Aug 2026, 5:22 pm
Invesco Mutual Fund Raises Stake in Dr. Agarwal's Healthcare Invesco Mutual Fund, through its various schemes, acquired 69,38,186 equity shares of Dr. Agarwal's Healthcare via an open market transaction on Aug 12, '26. This represents an additional 2.1885% of the company's share capital. Following the acquisition, Invesco's aggregate holding has increased from 3.0240% to 5.2125% of the paid-up share capital. This crosses the significant 5% ownership threshold, triggering a mandatory disclosure under SEBI's substantial acquisition regulations. The transaction does not involve any promoter group entities.
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Catalyst Trusteeship Ltd
Acquisition/ Disposal of Shares · 14 Aug 2026, 5:17 pm
Dr. Agarwal's Health Care: Partial Release of Pledged Shares Catalyst Trusteeship, acting for lenders to Hyperion Investments, disclosed a release of pledged shares in Dr. Agarwal's Health Care on 11 Aug'26. The release covers 31,698,303 shares, representing 10% of total voting capital. Following this, the encumbered shares held by the acquirer decreased from 73,193,988 shares (23.09%) to 41,495,685 shares (13.09%). This relates to a USD 100M facility agreement dated 26 Mar'24 where Hyperion Investments had pledged the shares as security.
The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for ICICI Prudential Mutual Fund
Acquisition/ Disposal of Shares · 14 Aug 2026, 5:08 pm
ICICI Prudential MF Acquires Over 5% Stake in Dr. Agarwal's Health Care ICICI Prudential Mutual Fund, via its various schemes, acquired 1,69,99,999 shares of Dr. Agarwal's Health Care Ltd on 12 Aug'26 through an open market transaction. This purchase increased its total shareholding to over 5% of the company's paid-up capital. Following the acquisition, ICICI Prudential MF's stake now stands at 5.36% of the total voting capital and 5.32% of the diluted share capital. The acquisition was made from an investment perspective, not to seek controlling interest.
Transcript of the discussion held on the Unaudited Financial Results (Consolidated & Standalone) of the Company for the quarter ended June 30, 2026, at the analyst call held on August 04, ....
Transcript · 08 Aug 2026, 12:08 am